KM Research Hub
← 返回论文库
无 KM 图 入排:排除 图源:可得 入排置信度 0.96

Evaluating the prognostic impact of multiple 18FDG-PET imaging parameters in small-cell lung cancer: Insights from the long-term analysis of the CONVERT trial.

Anubhav Datta, William Spiller, Hitesh Mistry, Peter Julyan, James Pb O'Connor, Ahmed Salem, Corinne Faivre-Finn, Prakash Manoharan

Eur J Nucl Med Mol Imaging 53(8) 4944-4954

PMID41801367
PMCIDPMC13249784
DOI10.1007/s00259-026-07812-7
发表日期2026-03-09
入排依据:属于事后亚组、二次、生活质量或卫生经济学分析,不作为原始随机试验结果纳入。
已检查 2 张 PubMed Figure,均未识别为 KM 图:Fig. 1:森林图/亚组分析图;Fig. 2:AI 判定为 other。
摘要

摘要

BACKGROUND: The prognostic value of baseline 18F-FDG PET/CT-derived metrics in limited-stage small-cell lung cancer (LS-SCLC) remains uncertain. We evaluated whether baseline PET-derived parameters provide prognostic information beyond tumour volume and clinical factors in patients treated with curative-intent chemoradiotherapy within the phase III CONVERT trial. METHODS: CONVERT was an international, multi-centre randomised controlled trial. This study is a post-hoc analysis of baseline 18F-FDG PET/CT from the multiple PET imaging parameter (MPI) cohort across 8 UK sites. PET metrics, including whole-body metabolic tumour volume (MTV), total lesion glycolysis (TLG), SUV-based measures, and radiomic features, were derived under EARL-accredited conditions. CT-derived gross tumour volume (GTV) and a pre-specified clinical prognostic model (CPM) were assessed alongside PET metrics. Overall survival (OS) and progression-free survival (PFS) were analysed using Cox regression. Incremental prognostic value beyond CPM was evaluated using Harrell’s concordance index (C-index). Correlations between imaging, clinical, and circulating tumour cell (CTC) variables were explored. RESULTS: Ninety-four patients comprised the MPI cohort. In univariable analyses, CPM, CT-GTV, and PET-derived MTV and TLG, were associated with shorter OS and PFS. After multivariable adjustment, only CT-GTV remained independently prognostic for OS (HR 1.36, 95% CI 1.06–1.74) and PFS (HR 1.29, 95% CI 1.03–1.63). CPM demonstrated moderate prognostic discrimination (C-index 0.63 for OS; 0.59 for PFS). Addition of SUV-based PET metrics did not improve discrimination beyond CPM (ΔC-index ≤ 0.002). PET-derived volumetric parameters were strongly correlated with CT-GTV and CPM, indicating redundancy. Circulating tumour cell counts, available in a subset, showed no significant correlations. CONCLUSIONS: In LS-SCLC treated with curative-intent chemoradiotherapy, baseline tumour volume is the dominant prognostic determinant. Baseline 18F-FDG PET-derived metabolic and radiomic parameters do not provide meaningful incremental prognostic value beyond tumour burden and clinical factors. While PET/CT remains essential for staging and treatment selection, its role in baseline prognostic stratification appears limited.

KM 提取结果

0 个 Figure · 0 个 KM 面板

尚未提取到 KM 面板。
其他 Figure(2,默认折叠)

这些图片未产生 KM 曲线结果,不在主页面重复展示。

Fig. 1Fig. 1 Non-linear associations between selected CT- and PET-derived imaging parameters and ( A ) overall survival and ( B ) progression-free survival, modelled using penalised smoothing splines. Solid lines represent estimated log hazard ratios relative to the median predictor value, with shaded areas indicating 95% confidence intervals. P-values reflect the overall association from likelihood ratio testing
非 KM Figure
Fig. 2Fig. 2 Spearman correlation heatmap showing relationships between PET-derived whole-body imaging features, CT-based gross tumour volume, the clinical prognostic model (CPM), and circulating tumour cell counts. Colour intensity represents the magnitude and direction of correlation (blue, negative; red, positive). Variables are hierarchically clustered to highlight patterns of similarity. Circulating tumour cell counts showed no significant correlations with imaging-derived or clinical variables
非 KM Figure